10 Lupus Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Lupus Studies in Bethesda

NCT00001372Recruiting

Study of Systemic Lupus Erythematosus

This protocol will evaluate patients with systemic lupus erythematosus (SLE) and their relatives to learn more about how the disease develops and changes over time. It will also study genetic factors ...

Bethesda, MD2,000 participantsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

View Study Details

NCT07121452Recruiting

Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System

The long-term goal of this research is to improve military health and operational readiness among military service members with sleep disorders. The overall objective of the current study is to 1) det...

Bethesda, MDNA160 participantsUniformed Services University of the Health Sciences

View Study Details

NCT06897930Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

This is a Phase 1b/2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19/BCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants wit...

Bethesda, MDPHASE1150 participantsAstraZeneca

View Study Details

NCT05052216Recruiting

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Background: Obstructive sleep apnea (OSA) occurs when the blockage of the airway causes a person to stop breathing involuntarily for 10 seconds or more throughout the night during sleep. Pediatric OS...

Bethesda, MD120 participantsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

View Study Details

NCT05835310Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...

Bethesda, MDPHASE3100 participantsAstraZeneca

View Study Details

NCT05567198Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Background: Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. People with SLE are often treated with cyclophosphamide (CYC). But CYC can damage a ...

Bethesda, MD100 participantsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

View Study Details

NCT06032923Recruiting

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Study Description: Systemic lupus erythematosus (SLE) occurs predominantly in women and is driven by type I interferon dysregulation and neutrophil hyperresponsiveness. Neutrophils in females have re...

Bethesda, MDPHASE178 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT07301710Recruiting

Low-Tech Treatments for Obstructive Sleep Apnea

The overall purpose of this study is to compare changes in sleep outcomes in people with obstructive sleep apnea (OSA) depending on their participation in one of two behavioral interventions; both inv...

Bethesda, MDPHASE160 participantsUniformed Services University of the Health Sciences

View Study Details

NCT05440422Recruiting

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke. No medications have b...

Bethesda, MDPHASE245 participantsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

View Study Details

NCT02945501Recruiting

Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep

The purpose of this study is to determine if the enhancement of electroencephalographic (EEG) slow-wave activity using transcranial electrical stimulation (TES) at Slow Oscillation (SO) frequency, dur...

Bethesda, MDNA40 participantsU.S. Army Medical Research and Development Command

View Study Details

About Lupus Clinical Trials in Bethesda

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 10 lupus clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 2,853 participants. Research is being sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Uniformed Services University of the Health Sciences, AstraZeneca and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in Bethesda — FAQ

Are there lupus clinical trials in Bethesda?

Yes, there are 10 lupus clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What lupus treatments are being tested?

The 10 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 18, 2026 from ClinicalTrials.gov